Trial Profile
A retrospective pharmacokinetic and pharmacodynamic study of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant (HSCT) patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2015
Price :
$35
*
At a glance
- Drugs Meropenem (Primary)
- Indications Bacterial infections
- Focus Pharmacodynamics; Pharmacokinetics
- 05 Oct 2015 New trial record